Skip to main content
. 2017 Feb 24;8(19):30781–30792. doi: 10.18632/oncotarget.15683

Table 1. Baseline characteristics of the enrolled patients.

Variables CHB group (n = 205) HC group (n = 15) P Values
Male (n, %) 152(74.1) 11(73.3) 0.945a
Age (years) 40(28-47) 38(26-45) >0.05b
HBeAg+(n, %) 140(68.3) NA
HBVDNA+(n, %) 164(80.0) NA
Log10 (HBVDNA load) 5.74(3.92-7.22) NA
HBsAg(IU/mL) 3769(994.5-5711) NA
ALT (U/L) 120(39-265.5) 16(12.0-25.0) <0.001b
AST (U/L) 57(32.5-132) 12(7.0-20.5) <0.001b
TBIL (umol/L) 17.7(11.7-41.7) 10.5(6.7-12.3) <0.001b
ALB (g/L) 42(37.7-45.1) 50(42-61) <0.001b
PT-INR 1.00(0.95-1.06) 0.80(0.72-1.01) 0.688b
PTA (%) 92(77.5-102) 89(78-93) 0.237b
AFP (ng/ml) 29.6(13.2-41.2) 25(19-31) <0.001b
Cr (umol/L) 62(52-69.6) 63(52-69) 0.282b
WBC (E+09/L) 5.40(4.60-6.69) 7.65(6.32-8.65) <0.001b
HGB (g/L) 125(110-145.5) 143(130-156) <0.001b
PLT (E+09/L) 187(154-225.5) 201(157-234) 0.006b

Quantitative variables were expressed as the median (centile 25; centile 75).

Categorical variables were expressed as number (%).